nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0697	0.0941	CcSEcCtD
Oxazepam—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0627	0.0847	CcSEcCtD
Oxazepam—Incontinence—Furosemide—dilated cardiomyopathy	0.0601	0.0811	CcSEcCtD
Oxazepam—Drug eruption—Furosemide—dilated cardiomyopathy	0.0341	0.0461	CcSEcCtD
Oxazepam—Lethargy—Spironolactone—dilated cardiomyopathy	0.0286	0.0386	CcSEcCtD
Oxazepam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0263	0.0356	CcSEcCtD
Oxazepam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0216	0.0291	CcSEcCtD
Oxazepam—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0201	0.0272	CcSEcCtD
Oxazepam—Memory impairment—Lisinopril—dilated cardiomyopathy	0.0201	0.0271	CcSEcCtD
Oxazepam—Lethargy—Furosemide—dilated cardiomyopathy	0.0155	0.021	CcSEcCtD
Oxazepam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0151	0.0204	CcSEcCtD
Oxazepam—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.0131	0.0177	CcSEcCtD
Oxazepam—Somnolence—Spironolactone—dilated cardiomyopathy	0.0122	0.0165	CcSEcCtD
Oxazepam—Drowsiness—Furosemide—dilated cardiomyopathy	0.0117	0.0159	CcSEcCtD
Oxazepam—Diplopia—Lisinopril—dilated cardiomyopathy	0.0114	0.0154	CcSEcCtD
Oxazepam—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.011	0.0148	CcSEcCtD
Oxazepam—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0109	0.0147	CcSEcCtD
Oxazepam—Ataxia—Lisinopril—dilated cardiomyopathy	0.0107	0.0145	CcSEcCtD
Oxazepam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0101	0.0137	CcSEcCtD
Oxazepam—Dizziness—Spironolactone—dilated cardiomyopathy	0.0091	0.0123	CcSEcCtD
Oxazepam—Rash—Spironolactone—dilated cardiomyopathy	0.00868	0.0117	CcSEcCtD
Oxazepam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00867	0.0117	CcSEcCtD
Oxazepam—Vision blurred—Furosemide—dilated cardiomyopathy	0.00864	0.0117	CcSEcCtD
Oxazepam—Headache—Spironolactone—dilated cardiomyopathy	0.00862	0.0116	CcSEcCtD
Oxazepam—Jaundice—Lisinopril—dilated cardiomyopathy	0.00858	0.0116	CcSEcCtD
Oxazepam—Agitation—Furosemide—dilated cardiomyopathy	0.00843	0.0114	CcSEcCtD
Oxazepam—Vertigo—Furosemide—dilated cardiomyopathy	0.00824	0.0111	CcSEcCtD
Oxazepam—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00822	0.0111	CcSEcCtD
Oxazepam—Leukopenia—Furosemide—dilated cardiomyopathy	0.00821	0.0111	CcSEcCtD
Oxazepam—Nausea—Spironolactone—dilated cardiomyopathy	0.00817	0.011	CcSEcCtD
Oxazepam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00787	0.0106	CcSEcCtD
Oxazepam—Shock—Furosemide—dilated cardiomyopathy	0.00737	0.00995	CcSEcCtD
Oxazepam—Hypotension—Furosemide—dilated cardiomyopathy	0.007	0.00945	CcSEcCtD
Oxazepam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00672	0.00908	CcSEcCtD
Oxazepam—Somnolence—Furosemide—dilated cardiomyopathy	0.00666	0.00899	CcSEcCtD
Oxazepam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00649	0.00876	CcSEcCtD
Oxazepam—Tremor—Lisinopril—dilated cardiomyopathy	0.00645	0.00871	CcSEcCtD
Oxazepam—Vertigo—Lisinopril—dilated cardiomyopathy	0.00618	0.00835	CcSEcCtD
Oxazepam—Syncope—Lisinopril—dilated cardiomyopathy	0.00617	0.00834	CcSEcCtD
Oxazepam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00616	0.00832	CcSEcCtD
Oxazepam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00612	0.00827	CcSEcCtD
Oxazepam—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00605	0.00817	CcSEcCtD
Oxazepam—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00592	0.00799	CcSEcCtD
Oxazepam—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00592	0.00799	CcSEcCtD
Oxazepam—Oedema—Lisinopril—dilated cardiomyopathy	0.00562	0.00759	CcSEcCtD
Oxazepam—Shock—Lisinopril—dilated cardiomyopathy	0.00553	0.00746	CcSEcCtD
Oxazepam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00552	0.00745	CcSEcCtD
Oxazepam—Hypotension—Lisinopril—dilated cardiomyopathy	0.00525	0.00709	CcSEcCtD
Oxazepam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00504	0.00681	CcSEcCtD
Oxazepam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00499	0.00674	CcSEcCtD
Oxazepam—Dizziness—Furosemide—dilated cardiomyopathy	0.00495	0.00669	CcSEcCtD
Oxazepam—Rash—Furosemide—dilated cardiomyopathy	0.00472	0.00638	CcSEcCtD
Oxazepam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00472	0.00637	CcSEcCtD
Oxazepam—Headache—Furosemide—dilated cardiomyopathy	0.00469	0.00633	CcSEcCtD
Oxazepam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00459	0.0062	CcSEcCtD
Oxazepam—Nausea—Furosemide—dilated cardiomyopathy	0.00445	0.00601	CcSEcCtD
Oxazepam—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00444	0.006	CcSEcCtD
Oxazepam—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00444	0.006	CcSEcCtD
Oxazepam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00414	0.00559	CcSEcCtD
Oxazepam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00371	0.00502	CcSEcCtD
Oxazepam—Rash—Lisinopril—dilated cardiomyopathy	0.00354	0.00478	CcSEcCtD
Oxazepam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00354	0.00478	CcSEcCtD
Oxazepam—Headache—Lisinopril—dilated cardiomyopathy	0.00352	0.00475	CcSEcCtD
Oxazepam—Nausea—Lisinopril—dilated cardiomyopathy	0.00334	0.00451	CcSEcCtD
Oxazepam—GABRQ—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00219	0.00844	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00219	0.00844	CbGpPWpGaD
Oxazepam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00207	0.00799	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00202	0.00779	CbGpPWpGaD
Oxazepam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00202	0.00777	CbGpPWpGaD
Oxazepam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00201	0.00776	CbGpPWpGaD
Oxazepam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00198	0.00762	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00196	0.00756	CbGpPWpGaD
Oxazepam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00196	0.00755	CbGpPWpGaD
Oxazepam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00194	0.00749	CbGpPWpGaD
Oxazepam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00193	0.00744	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00193	0.00743	CbGpPWpGaD
Oxazepam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00192	0.00741	CbGpPWpGaD
Oxazepam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0019	0.00731	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00189	0.0073	CbGpPWpGaD
Oxazepam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00189	0.00729	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00188	0.00725	CbGpPWpGaD
Oxazepam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00188	0.00724	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00185	0.00712	CbGpPWpGaD
Oxazepam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00185	0.00711	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00184	0.00707	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00181	0.00695	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00178	0.00685	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00176	0.00678	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—ABCC9—dilated cardiomyopathy	0.00175	0.00675	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00175	0.00675	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00171	0.00658	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00168	0.00648	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00168	0.00647	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—ACTN2—dilated cardiomyopathy	0.00168	0.00647	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00166	0.0064	CbGpPWpGaD
Oxazepam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00166	0.00639	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00162	0.00622	CbGpPWpGaD
Oxazepam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00161	0.00621	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00152	0.00585	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00148	0.00569	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00145	0.00558	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00144	0.00556	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00142	0.00549	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00142	0.00547	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00142	0.00545	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00139	0.00535	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00138	0.00533	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00136	0.00525	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00134	0.00518	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00133	0.00511	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00129	0.00497	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00127	0.0049	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00121	0.00468	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00121	0.00468	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00118	0.00454	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00116	0.00448	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00116	0.00446	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00114	0.00439	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00113	0.00436	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00113	0.00436	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ANKRD1—dilated cardiomyopathy	0.00112	0.00432	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00111	0.00428	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00111	0.00428	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00109	0.00421	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00109	0.0042	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00108	0.00418	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00106	0.0041	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00106	0.00409	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00106	0.00409	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—TAZ—dilated cardiomyopathy	0.00105	0.00406	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00104	0.00401	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00104	0.00401	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00101	0.0039	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00101	0.0039	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00101	0.0039	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00101	0.0039	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000987	0.0038	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000971	0.00374	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SDHA—dilated cardiomyopathy	0.000953	0.00367	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000942	0.00363	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000942	0.00363	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000931	0.00359	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000931	0.00359	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000876	0.00337	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ANKRD1—dilated cardiomyopathy	0.000866	0.00334	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000858	0.0033	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000845	0.00325	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000834	0.00321	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000834	0.00321	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000822	0.00317	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000822	0.00317	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TAZ—dilated cardiomyopathy	0.000814	0.00314	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000799	0.00308	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000789	0.00304	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00078	0.00301	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000778	0.003	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000778	0.003	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000776	0.00299	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000768	0.00296	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000768	0.00296	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000764	0.00294	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000763	0.00294	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SDHA—dilated cardiomyopathy	0.000736	0.00284	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000723	0.00278	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000722	0.00278	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000714	0.00275	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000702	0.00271	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000702	0.00271	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000702	0.00271	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000701	0.0027	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000699	0.00269	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000695	0.00268	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000689	0.00265	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000687	0.00265	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000682	0.00263	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000682	0.00263	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000677	0.00261	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000672	0.00259	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000671	0.00259	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00067	0.00258	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00067	0.00258	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000667	0.00257	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000663	0.00256	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000663	0.00256	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00066	0.00254	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000658	0.00254	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000658	0.00254	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000654	0.00252	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000654	0.00252	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000653	0.00251	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000642	0.00247	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000642	0.00247	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000639	0.00246	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000634	0.00244	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000632	0.00243	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000623	0.0024	CbGpPWpGaD
Oxazepam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000619	0.00238	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000612	0.00236	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000608	0.00234	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000597	0.0023	CbGpPWpGaD
Oxazepam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00059	0.00227	CbGpPWpGaD
Oxazepam—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.00059	0.00227	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000578	0.00223	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000577	0.00222	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000561	0.00216	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000561	0.00216	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000546	0.0021	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000538	0.00207	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000526	0.00203	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000523	0.00201	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000522	0.00201	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.00051	0.00197	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000509	0.00196	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000503	0.00194	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000499	0.00192	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000499	0.00192	CbGpPWpGaD
Oxazepam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000486	0.00187	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.00048	0.00185	CbGpPWpGaD
Oxazepam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000479	0.00184	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000474	0.00182	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00046	0.00177	CbGpPWpGaD
Oxazepam—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000453	0.00175	CbGpPWpGaD
Oxazepam—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000447	0.00172	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000447	0.00172	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000439	0.00169	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	0.000434	0.00167	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000431	0.00166	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000428	0.00165	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000421	0.00162	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000419	0.00161	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000415	0.0016	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000411	0.00158	CbGpPWpGaD
Oxazepam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000409	0.00158	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000405	0.00156	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000401	0.00154	CbGpPWpGaD
Oxazepam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000397	0.00153	CbGpPWpGaD
Oxazepam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00039	0.0015	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	0.00039	0.0015	CbGpPWpGaD
Oxazepam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000384	0.00148	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000383	0.00147	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000382	0.00147	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.000382	0.00147	CbGpPWpGaD
Oxazepam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000381	0.00147	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000378	0.00146	CbGpPWpGaD
Oxazepam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000374	0.00144	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000368	0.00142	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	0.000353	0.00136	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000349	0.00134	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000346	0.00133	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000336	0.00129	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00033	0.00127	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.000328	0.00126	CbGpPWpGaD
Oxazepam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000327	0.00126	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000324	0.00125	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000322	0.00124	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000316	0.00122	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000315	0.00121	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.00031	0.00119	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000297	0.00114	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000293	0.00113	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.00029	0.00112	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000276	0.00106	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000265	0.00102	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GPX1—dilated cardiomyopathy	0.000259	0.000997	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000257	0.000991	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000253	0.000973	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000252	0.000971	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CD36—dilated cardiomyopathy	0.000252	0.000971	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000248	0.000957	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000247	0.00095	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000242	0.000933	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000237	0.000913	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AGT—dilated cardiomyopathy	0.000227	0.000874	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00022	0.000848	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000215	0.00083	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000215	0.000829	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000214	0.000826	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000212	0.000816	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000209	0.000807	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000205	0.000791	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000205	0.000791	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GPX1—dilated cardiomyopathy	0.0002	0.000771	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CD36—dilated cardiomyopathy	0.000195	0.00075	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000189	0.000727	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AGT—dilated cardiomyopathy	0.000175	0.000676	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000169	0.000652	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000167	0.000642	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000158	0.000607	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000156	0.0006	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000142	0.000549	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000138	0.000533	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000136	0.000523	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000134	0.000514	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000133	0.000511	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00013	0.000502	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	0.000118	0.000454	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000117	0.000452	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	0.000115	0.000442	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000114	0.000439	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.00011	0.000425	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	0.000103	0.000398	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.97e-05	0.000384	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	9.58e-05	0.000369	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	9.33e-05	0.000359	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	8.4e-05	0.000324	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	8.06e-05	0.00031	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	7.85e-05	0.000302	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	7.06e-05	0.000272	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.82e-05	0.000224	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.67e-05	0.000218	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	5.11e-05	0.000197	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.71e-05	0.000104	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.64e-05	0.000102	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.37e-05	9.15e-05	CbGpPWpGaD
